Lipid-based amphotericin B formulations: From animals to man

Pharmaceutical Science and Technology Today

Volumn 2, Issue 6, 1999, Pages 230-236

  Bekersky, Ihor ^a   Fielding, Robert M ^b   Buell, Donald ^a   Lawrence, Ira ^a  

^a ASTELLAS PHARMA GLOBAL DEVELOPMENT   (United States)

^b Biologistic Services Boulder   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; DRUG CARRIER; LIPOSOME;

ANTIFUNGAL ACTIVITY; DOSE RESPONSE; DRUG BINDING; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NEPHROTOXICITY; PLASMA CLEARANCE; REVIEW; STREPTOMYCES; TISSUE DISTRIBUTION;

EID: 0033151650     PISSN: 14615347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1461-5347(99)00160-1     Document Type: Review

References (57)

1. Bodey G.P. J. Hosp. Infect. 11(Suppl. A):1988;411-426.
2. Beck S.C., Jarvis W.R. J. Infect. Dis. 167:1993;1247-1251.
3. Anaissie E.et al. Rev. Infect. Dis. 11:1989;369-378.
4. Andriole V.T. Curr. Clin. Top. Infect. Dis. 18:1998;19-36.
5. Gallis H.A., Drew R.H., Pickard W.W. Rev. Infect. Dis. 12:1990;308-329.
6. Sarosi G.A. Postgrad. Med. 88:1990;151-166.
7. Hamilton-Miller J.M.T. Adv. Appl. Microbiol. 17:1974;109-134.
8. Walsh T.J., Pizzo P.A. Eur. J. Clin. Microbiol. Infect. Dis. 7:1988;460-475.
9. Papahadjopoulos D. Ann. New York Acad. Sci. 308:1978;1-462.
10. Scherphof G.et al. Biochim. Biophys. Acta. 542:1978;296-307.
11. Chonn A., Semple S.C., Cullis P.R. J. Biol. Chem. 267:1992;18759-18765.
12. Senior J.H. Crit. Rev. Ther. Drug Carrier Syst. 3:1987;123-193.
13. Harashima H., Ohnishi Y., Kiwada H. Biopharm. Drug Dispos. 13:1992;549-553.
14. Fielding R.M., Mukwaya G., Sandhaus R.A. Long-Circulating Liposomes: Old Drugs, New Therapeutics. Woodle M.C., Storm G. 1998;213-225 Landes Bioscience.
15. New R.R., Chance M.L., Heath S. J. Antimicrob. Chemother. 8:1981;371-381.
16. Lopez-Berestein G.et al. J. Infect. Dis. 150:1984;278-283.
17. Lopez-Berestein G.et al. J. Infect. Dis. 151:1985;704-710.
18. Sculier J-P.et al. Eur. J. Cancer Clin. Oncol. 24:1988;527-538.
19. Janoff A.S.et al. Proc. Natl. Acad. Sci. U. S. A. 85:1988;6122-6126.
20. Adler-Moore J., Proffitt R.T. J. Liposome Res. 3:1993;429-450.
21. Guo L.S.S.et al. Int. J. Pharm. 75:1991;45-54.
22. Janoff A.S.et al. J. Liposome Res. 3:1993;451-471.
23. Hiemenz J.W., Walsh T.J. Clin. Infect. Dis. 22(Suppl.2):1996;S133-S144.
24. Wong-Beringer A., Jacobs R.A., Guglielmo B.J. Clin. Infect. Dis. 27:1998;603-618.
25. Sharkey P.K.et al. Clin. Infect. Dis. 22:1996;315-321.
26. Szoka F.C., Milholland D., Barza M. Antimicrob. Agents Chemother. 31:1987;421-429.
27. Fielding R.M.et al. Antimicrob. Agents Chemother. 36:1992;299-307.
28. Wang L.H.et al. Pharm. Res. 12:1995;275-283.
29. Guo L.S.S., Working P.K. J. Liposome Res. 3:1993;473-490.
30. Sanders S.W.et al. Antimicrob. Agents Chemother. 35:1991;1029-1034.
31. White M.H.et al. Clin. Infect. Dis. 24:1997;635-642.
32. Oppenheim B.A., Herbrecht R., Kusne S. Clin. Infect. Dis. 21:1995;1145-1153.
33. Bowden R.A.et al. J. Infect. Dis. 173:1996;1208-1215.
34. Anaissie E.J.et al. Antimicrob. Agents Chemother. 42:1998;606-611.
35. Adler-Moore J., Proffitt R.T. Long-Circulating Liposomes: Old Drugs, New Therapeutics. Woodle M.C., Storm G. 1998;185-206 Landes Bioscience.
36. Proffitt R.T.et al. J. Antimicrob. Chemother. 28(Suppl. B):1991;49-61.
37. Boswell G.W.et al. Antimicrob. Agents Chemother. 42:1998;263-268.
38. Walsh T.J.et al. Antimicrob. Agents Chemother. 42:1998;2391-2398.
39. Boswell G.W., Buell D., Bekersky I. J. Clin. Pharmacol. 38:1998;583-592.
40. Munier F., Prentice H.G., Ringden O. J. Antimicrob. Chemother. 28(Suppl. B):1991;83-91.
41. Ringden O.et al. J. Antimicrob. Chemother. 28(Suppl. B):1991;73-82.
42. Mills W.et al. Br. J. Haematol. 86:1994;754-760.
43. Coker R.J.et al. AIDS. 7:1993;829-835.
44. Prentice H.G.et al. Br. J. Haematol. 98:1997;711-718.
45. Walsh T.J. New Eng. J. Med. 340:1999;764-771.
46. Meyerhoff A. Clin. Infect. Dis. 28:1999;42-48.
47. Hiemenz J.W., Cagnoni P., Tong K. Focus on Fungal Infections. 8:1998;. Abstr. 37.
48. Koldin M.H.et al. Antimicrob. Agents Chemother. 28:1985;144-145.
49. Bolard J., Joly V., Yeni P. J. Liposome Res. 3:1993;409-427.
50. Adler-Moore J. Bone Marrow Transplant. 14(Suppl. 5):1994;S3-S7.
51. Edmonds L.C., Davidson L., Bertino J.S. J. Antimicrob. Chemother. 28:1991;919-924.
52. Jahn B.et al. Antimicrob. Agents Chemother. 42:1998;2569-2575.
53. Mehta R.T.et al. Chemotherapy. 40:1994;256-264.
54. Clemons K.V., Stevens D.A. Antimicrob. Agents Chemother. 42:1998;899-902.
55. van Etten E.W.M.et al. Antimicrob. Agents Chemother. 42:1998;2431-2433.
56. Saxena S., Khan J.A., Ghosh P.C. J. Antimicrob. Chemother. 42:1998;635-642.
57. Wallace T.L.et al. Antimicrob. Agents Chemother. 41:1997;2238-2243.